Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: futurism

Humanity’s Endgame? We Built an AI That Will Command Us — MO Gawdat

🏦 Invest In Luxury Dubai Property https://londonreal.tv/dubai-ytd
🍿 Watch the full interview for free at https://londonreal.tv/gawdat.

In this powerful episode, Brian Rose sits down with former Google X exec and bestselling author Mo Gawdat 🧠 to explore the mind-blowing future of Artificial Intelligence 🤯. From the rise of machine learning to the ethical dangers of unchecked AI evolution ⚠️, this conversation uncovers why AI is the infant that could soon become our master.

🔥 Discover the truth about what’s coming

⚙️ Why we must act now to guide its growth
🧘♂️ And how mindfulness may be our only defense.

This one will change how you see the future 🌍💡
👉 Don’t miss it — hit play now and prepare your mind.

🚨 Learn To Make Money In Crypto:
💰The Investment club: https://londonreal.tv/club
💰Crypto & DeFi Academy: https://londonreal.tv/defi-ytd.

🔔 SUBSCRIBE ON YOUTUBE: http://bit.ly/SubscribeToLondonReal

Continue reading “Humanity’s Endgame? We Built an AI That Will Command Us — MO Gawdat” | >

Yann Le Cun : « Ce que nous construisons, c’est ni plus ni moins que le cortex préfontal des machines »

ENTRETIEN. Pour le chercheur, Prix Turing 2018, la prochaine révolution robotique – celle de systèmes vraiment autonomes et dotés d’une véritable compréhension du réel – n’est possible que si l’on ancre l’IA dans le monde physique.

Leukemia stem cells cause treatments to fail, but findings open new avenues to overcome resistance

Scientists from the German Cancer Research Center (DKFZ) and the HI-STEM Stem Cell Institute have deciphered a key mechanism that contributes to treatment failure in acute myeloid leukemia (AML). They show that there are not just one, but four different subtypes of leukemia stem cells. This diversity could explain why one of the most important AML drugs does not work sufficiently in some patients or loses its effectiveness over time—resulting in the return of leukemia.

This discovery lays an important foundation for more precise and long-term successful treatment strategies that could specifically overcome resistance mechanisms. The findings are published in the journal Cell Stem Cell.

Acute myeloid leukemia (AML) is an aggressive form of blood cancer that primarily affects older people and often has a poor prognosis despite improved therapies. In recent years, the targeted drug venetoclax has significantly improved treatment. In combination with other drugs, venetoclax often shows good therapeutic success in AML and will, at least in part, replace highly aggressive chemotherapy in the future. However, AML returns in nearly all patients—usually because individual cancer stem cells become resistant to the drug.

New Cisco DoS flaw requires manual reboot to revive devices

The company advised customers at the time to contact its Technical Assistance Center (TAC) to have them brought back online, as this required manual intervention.

Last year, Cisco patched another DoS vulnerability (CVE-2025–20115) that allowed attackers to crash the Border Gateway Protocol (BGP) process on IOS XR routers with a single BGP update message.

/* */